News
- 2023-04-20Vitiligo is a skin condition that affects up to 1.11% of the US population, causing loss of skin color and creating white patches on the skin. It can be especially upsetting when it affects the face, where it's more noticeable. Until recently, tre...
- 2023-04-18The official logo for World Vitiligo Day (WVD) 2023, to be held in Kazakhstan, has been unveiled. This logo was crafted by local artist Zhanar Sagidolla, who emerged as the winner in the logo design contest. The competition was overseen by the WVD...
- 2023-04-12Can you imagine waking up one day to find that the person in the mirror no longer resembles the one you've always known? For Valarie Molyneaux, this was her reality when she was diagnosed with vitiligo - a condition that causes the skin to lose it...
- 2023-04-10Calling all vitiligo patients in the Tristate area! Liz Lewis Casting Partners and SELF by Conde Nast are collaborating on a project that highlights and educates on the impact of vitiligo. We are currently looking for individuals to share their pe...
- 2023-04-03Today we celebrate the outstanding achievement of Prof. Torello Lotti, the esteemed Chair of the Scientific Board of Vitiligo Research Foundation. The Italian Republic has recognized his exceptional contributions to academia by awarding him the di...
- 2023-03-30Mark your calendars and pack your sunscreen! On June 25th, 2023, a brilliant beacon will shine on vitiligo as the thirteenth annual World Vitiligo Day (WVD) unfolds in Almaty, Kazakhstan. This vibrant global event unites researchers, doctors, and...
- 2023-03-22A recent study presented at the GVF Annual Scientific Symposium in New Orleans has shown promising results in treating vitiligo. Led by Dr. Ammar Ahmed from the University of Texas at Austin Dell Medical School, the study utilized TruPigment™ by T...
- 2023-03-20Biopharmaceutical company Incyte has recently revealed promising results from a clinical trial focusing on the safety and efficacy of povorcitinib in adult patients with extensive vitiligo. The findings were presented at the American Academy of De...
- 2023-03-18Incyte unveiled intriguing 104-week results from its pivotal Phase 3 TRuE-V clinical trial program, which assessed Opzelura® (ruxolitinib) cream 1.5% in nonsegmental vitiligo patients aged 12 and older. These findings, presented at the 2023 Americ...
- 2023-02-25Boost your weekend mood with some good news: The European Medicines Agency expressed a positive opinion on Opzelura earlier this week. The green light opens the fast track for it to become the first ‘official’ vitiligo therapy in the EU. Incyte...
- 2023-02-24Great news for the vitiligo community in the EU! Incyte has just announced in a press-release that ruxolitinib cream (Opzelura™) has received a positive opinion from the European Medicines Agency (EMA) committee for the treatment of vitiligo with...
- 2023-02-22Vitiligo is a complex and puzzling autoimmune disorder that causes the loss of pigment-producing cells called melanocytes, leading to white patches on the skin. While the exact cause of vitiligo remains unknown, researchers believe both genetic an...
- 2023-02-16VYNE Therapeutics Inc. recently announced positive results from the Phase 1a portion of its Phase 1a/b clinical trial evaluating its novel BET inhibitor, VYN201, for vitiligo. This drug candidate is a locally administered, small molecule, pan-bro...
- 2023-02-14Just before the Valentine's Day, our Instagram community expressed their ambitions for this year. Amongst the variety of goals shared, two themes emerged - to 'experience something new' and to 'eliminate white spots'. Here are highlights from ou...
- 2023-02-08In this newsletter, we discuss the latest research, current treatments, and potential developments in the field. Examine the correlations between the incidence of vitiligo and the chemical variables that influence the condition. Read the latest cl...
- 2023-02-06Clinical trials are experiments that test how well new drugs, treatments or devices work in people. Trials progress through Phases I-IV to test a drug candidate, find the appropriate dosage, and look for side effects. The goal is to determine whet...
- 2023-01-31Are you an Adult or Adolescent (age 12 – 17) with nonsegmental vitiligo? Nonsegmental means vitiligo on both sides of your body. If so, you may qualify to take part in a non-treatment research interview study asking you about your experiences wit...
- 2023-01-27Research and treatments for vitiligo have seen a significant increase in recent years, offering new possibilities. The treatment options for vitiligo are rapidly expanding, with the first Food and Drug Administration-approved treatment leading t...
- 2023-01-24Sharing a nationwide call for teens 12-18 and adults 55-70 years old of any ethnicity with the most common, generalized form of vitiligo. Shoots in NYC next week (travel provided). Pays $1k/shoot + $2k buyout. To respond, please fill out this f...
- 2023-01-16Actress, singer and producer Mamta Mohandas revealed that she is suffering from vitiligo, - on Instagram with a picture of herself and a poem: "Dear Sun ☀️, I embrace you now like I have never before. So Spotted, I’m losing colour… I rise e...
- 2023-01-10Meet 22-year-old Tanya Manhenga, — one of contestants of a hit dating TV show “Love Island.” Manhenga is one of the ten Islanders who will be in South Africa for six weeks looking for love in the new villa. Love Island UK, winter season 2023, ki...
- 2023-01-04Pune-based startup Ahammune Biosciences has recently completed the phase 1 clinical trials of its investigational new drug AB1001, being developed as a topical therapy for vitiligo. Dr T. Balganesh, Chairman of Ahammune’s Board said, “Vitiligo i...
- 2023-01-03While 2022 didn't unfold as any of us had hoped, we are grateful for what we accomplished with your support as we look back. The Vitiligo Research Foundation (VRF) has made a notable mark on the world-wide vitiligo community, from providing educat...
- 2022-12-12New research suggests that exposure to phenols and catechols raising the risk of vitiligo onset by 4 times. The study conducted at the University of Sfax in Tunisia indicated the following risk factors for vitiligo: household chemical use hair...
- 2022-11-14Researchers from Northwestern University are conducting a research survey on the use of natural remedies, supplements and camouflage by vitiligo patients, so that dermatologists can provide them with more competent and relevant care. Investigat...
FAQOther Questions
- Does halo nevi affect vitiligo development?
Halo nevi (also known as Sutton's nevi) are characterized by a mole that's surrounded by a ring of depigmented or lighter skin. While both halo nevi and vitiligo involve the des...
- Is there a special diet for vitiligo?
In short, no. Some people find that certain foods may worsen their vitiligo symptoms or that others may improve their skin condition. We found no scientific evidence that a sp...
- I have vitiligo: will my children have vitiligo, too?
Children born to parents who both have the disorder are more likely to develop vitiligo. However, most children will not get vitiligo even if one parent has it. In children with...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.